These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38736482)

  • 1. Corrigendum: Pediatric CNS tumors and 2021 WHO classification: what do oncologists need from pathologists?
    d'Amati A; Bargiacchi L; Rossi S; Carai A; Bertero L; Barresi V; Errico ME; Buccoliero AM; Asioli S; Marucci G; Del Baldo G; Mastronuzzi A; Miele E; D'Antonio F; Schiavello E; Biassoni V; Massimino M; Gessi M; Antonelli M; Gianno F
    Front Mol Neurosci; 2024; 17():1411360. PubMed ID: 38736482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric CNS tumors and 2021 WHO classification: what do oncologists need from pathologists?
    d'Amati A; Bargiacchi L; Rossi S; Carai A; Bertero L; Barresi V; Errico ME; Buccoliero AM; Asioli S; Marucci G; Del Baldo G; Mastronuzzi A; Miele E; D'Antonio F; Schiavello E; Biassoni V; Massimino M; Gessi M; Antonelli M; Gianno F
    Front Mol Neurosci; 2024; 17():1268038. PubMed ID: 38544524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of the Recent Changes in the WHO Classification for Pediatric Brain and Spinal Cord Tumors.
    Halfpenny AM; Wood MD
    Pediatr Neurosurg; 2023; 58(5):337-355. PubMed ID: 36617415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Pediatric Neuro-Oncology Resources Available in Chile.
    Abu-Arja MH; Rojas Del Río N; Morales La Madrid A; Lassaletta A; Coven SL; Moreno R; Valero M; Perez V; Espinoza F; Fernandez E; Santander J; Tordecilla J; Oyarce V; Kopp K; Bartels U; Qaddoumi I; Finlay JL; Cáceres A; Reyes M; Espinoza X; Osorio DS
    JCO Glob Oncol; 2021 Mar; 7():425-434. PubMed ID: 33788596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Practical Approach to the Evaluation and Diagnosis of Pediatric CNS Tumors.
    Cotter JA; Viaene AN; Santi M; Hawkins C; Judkins AR
    Pediatr Dev Pathol; 2022; 25(1):6-9. PubMed ID: 33872110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric high-grade gliomas and the WHO CNS Tumor Classification-Perspectives of pediatric neuro-oncologists and neuropathologists in light of recent updates.
    Gielen GH; Baugh JN; van Vuurden DG; Veldhuijzen van Zanten SEM; Hargrave D; Massimino M; Biassoni V; Morales la Madrid A; Karremann M; Wiese M; Thomale U; Janssens GO; von Bueren AO; Perwein T; Nussbaumer G; Hoving EW; Niehusmann P; Gessi M; Kwiecien R; Bailey S; Pietsch T; Andreiuolo F; Kramm CM
    Neurooncol Adv; 2022; 4(1):vdac077. PubMed ID: 35733513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHO CNS5 2021 classification of gliomas: a practical review and road signs for diagnosing pathologists and proper patho-clinical and neuro-oncological cooperation.
    Sejda A; Grajkowska W; Trubicka J; Szutowicz E; Wojdacz T; Kloc W; Iżycka-Świeszewska E
    Folia Neuropathol; 2022; 60(2):137-152. PubMed ID: 35950467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cIMPACT-NOW updates and their significance to current neuro-oncology practice.
    Gonzalez Castro LN; Wesseling P
    Neurooncol Pract; 2021 Feb; 8(1):4-10. PubMed ID: 33664964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular testing for adolescent and young adult central nervous system tumors: A Canadian guideline.
    Lim-Fat MJ; Macdonald M; Lapointe S; Climans SA; Cacciotti C; Chahal M; Perreault S; Tsang DS; Gao A; Yip S; Keith J; Bennett J; Ramaswamy V; Detsky J; Tabori U; Das S; Hawkins C
    Front Oncol; 2022; 12():960509. PubMed ID: 36249063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of the CNS TAP tool for the selection of precision medicine therapies in neuro-oncology.
    Linzey JR; Marini BL; Pasternak A; Smith C; Miklja Z; Zhao L; Kumar-Sinha C; Paul A; Harris N; Robertson PL; Hoffman LM; Chinnaiyan A; Mody R; Koschmann C
    J Neurooncol; 2018 Mar; 137(1):155-169. PubMed ID: 29235051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Classification for Central Nervous System Tumors: Implications for Diagnosis and Therapy.
    Fuller CE; Jones DTW; Kieran MW
    Am Soc Clin Oncol Educ Book; 2017; 37():753-763. PubMed ID: 28561665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The therapy of infantile malignant brain tumors: current status?
    Kalifa C; Grill J
    J Neurooncol; 2005 Dec; 75(3):279-85. PubMed ID: 16195802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges and opportunities to advance pediatric neuro-oncology care in the developing world.
    Chan MH; Boop F; Qaddoumi I
    Childs Nerv Syst; 2015 Aug; 31(8):1227-37. PubMed ID: 26040936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current practice of cancer predisposition testing in pediatric patients with CNS tumors in the United States.
    Roy B; Knapke S; Pillay-Smiley N; Zhang X; Queen K; Sisson R
    Pediatr Blood Cancer; 2024 Jan; 71(1):e30725. PubMed ID: 37859593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician, patient, and caregiver support for a formal certification in pediatric neuro-oncology: A survey-based report from the SNO pediatrics working group.
    Lindsay HB; Cheng S; Fisher PG; Peters KB; Walsh KM; Ashley DM; Huang A
    Neurooncol Adv; 2023; 5(1):vdad130. PubMed ID: 37964897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.
    Sturm D; Capper D; Andreiuolo F; Gessi M; Kölsche C; Reinhardt A; Sievers P; Wefers AK; Ebrahimi A; Suwala AK; Gielen GH; Sill M; Schrimpf D; Stichel D; Hovestadt V; Daenekas B; Rode A; Hamelmann S; Previti C; Jäger N; Buchhalter I; Blattner-Johnson M; Jones BC; Warmuth-Metz M; Bison B; Grund K; Sutter C; Hirsch S; Dikow N; Hasselblatt M; Schüller U; Koch A; Gerber NU; White CL; Buntine MK; Kinross K; Algar EM; Hansford JR; Gottardo NG; Schuhmann MU; Thomale UW; Hernáiz Driever P; Gnekow A; Witt O; Müller HL; Calaminus G; Fleischhack G; Kordes U; Mynarek M; Rutkowski S; Frühwald MC; Kramm CM; von Deimling A; Pietsch T; Sahm F; Pfister SM; Jones DTW
    Nat Med; 2023 Apr; 29(4):917-926. PubMed ID: 36928815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response Assessment in Neuro-Oncology Clinical Trials.
    Wen PY; Chang SM; Van den Bent MJ; Vogelbaum MA; Macdonald DR; Lee EQ
    J Clin Oncol; 2017 Jul; 35(21):2439-2449. PubMed ID: 28640707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating molecular markers into the World Health Organization classification of CNS tumors: a survey of the neuro-oncology community.
    Aldape K; Nejad R; Louis DN; Zadeh G
    Neuro Oncol; 2017 Mar; 19(3):336-344. PubMed ID: 27688263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current state of radiomics in pediatric neuro-oncology practice: a systematic review.
    Albalkhi I; Bhatia A; Lösch N; Goetti R; Mankad K
    Pediatr Radiol; 2023 Sep; 53(10):2079-2091. PubMed ID: 37195305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system germ cell tumor, an archetypal AYA tumor and a model for pediatric and neuro-oncology collaboration, review from the EURACAN domain 10 group.
    Faure Conter C; Calaminus G; Nicholson J; Idbaih A; Hoang Xuan K; Vasiljevic A; Morana G; Szathmari A; Ajithkumar T; Frappaz D
    Front Oncol; 2022; 12():971697. PubMed ID: 36248981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.